Opt-in versus universal codeine provision for medical abortion up to 10 weeks of gestation at British Pregnancy Advisory Service: a cross-sectional evaluation.

Neda Taghinejadi Hannah McCulloch Michal Krassowski Amelia McInnes-Dean Katherine C Whitehouse Patricia A Lohr

Published in: BMJ sexual & reproductive health (2024)

Our findings suggest that patients have a better experience with pain management during medical abortion when able to opt-in to codeine provision following counselling versus receiving this medication routinely.

Keyphrases

pain management
healthcare
end stage renal disease
palliative care
newly diagnosed
ejection fraction
chronic kidney disease
mental health
chronic pain
preterm infants
peritoneal dialysis
prognostic factors
preterm birth
gestational age
smoking cessation
patient reported outcomes
human immunodeficiency virus